Foghorn Therapeutics Inc (FHTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 92,795 | 15,522 | N/A | N/A |
| Marketable Securities | 92,975 | N/A | N/A | N/A |
| TOTAL | $190,687 | $16,885 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 19,528 | 2,683 | N/A | N/A |
| Other Non-Current Assets | 45,379 | 2,774 | 0 | 0 |
| TOTAL | $64,907 | $5,457 | $N/A | $N/A |
| Total Assets | $255,594 | $22,342 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 3,680 | 3,439 | 0 | 0 |
| Accrued Expenses | 9,161 | 3,701 | N/A | N/A |
| TOTAL | $18,846 | $12,652 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 19,654 | 10,960 | N/A | N/A |
| Deferred Revenues | 2,024 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 58,361 | 202 | 0 | 0 |
| TOTAL | $90,561 | $11,162 | $N/A | $N/A |
| Total Liabilities | $109,407 | $23,814 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 36,817 | N/A | N/A | N/A |
| Common Shares | 4 | N/A | N/A | N/A |
| Retained earnings | -162,936 | -94,136 | N/A | N/A |
| Other shareholders' equity | -7 | 86,544 | 0 | 0 |
| TOTAL | $146,187 | $-1,472 | $N/A | $N/A |
| Total Liabilities And Equity | $255,594 | $22,342 | $0 | $0 |